Target intelligence / Profile preview

Immune system via paracrine factors and cell-cell contact

Molecular classification
Other
01

Overview

The immune system via paracrine factors and cell-cell contact describes the dual modalities of communication used by leukocytes to coordinate host defense and maintain self-tolerance. Paracrine signaling involves the secretion of soluble mediators, such as cytokines and chemokines, which bind to receptors on adjacent cells to initiate signaling cascades (NIH, 2023). Cell-cell contact, or juxtacrine signaling, requires direct physical interaction between surface molecules, exemplified by the immunological synapse where T-cell receptors engage MHC-peptide complexes (Nature Reviews Immunology, 2018). These mechanisms are critical in the tumor microenvironment, where cancer cells often exploit cell-cell contact (e.g., PD-L1) or paracrine factors (e.g., TGF-beta) to suppress immune surveillance (PubMed, 2021). While this entry encompasses a broad range of biological processes, therapeutic agents typically target specific nodes within these networks, such as monoclonal antibodies that neutralize cytokines or inhibitors that block checkpoint receptors (StatPearls, 2023). Consequently, this term represents a physiological framework rather than a single druggable molecular target.

Other names
Immune cell communicationParacrine and juxtacrine immune signalingImmune synapse and secretomeIntercellular immune signaling
02

Mechanism of action

Modulation of immune signaling through the inhibition or activation of specific cytokines (paracrine) or membrane-bound checkpoint receptors and ligands (cell-cell contact).

03

Biological functions

Immune responseSignal transductionCell-cell communicationParacrine signalingJuxtacrine signaling
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Severe immunosuppressionAutoimmunityInfusion-related reactions
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Cytokine profiles (e.g., IL-6, TNF-alpha)PD-L1 expression levelsC-reactive protein (CRP)T-cell surface markers (CD4, CD8, CD25)Soluble IL-2 receptor

Beyond the preview

Go deeper on Immune system via paracrine factors and cell-cell contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system via paracrine factors and cell-cell contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call